期刊文献+

保健食品中非法添加物西布曲明、N-单去甲基西布曲明质控样品的研制 被引量:9

Preparation of quality control samples for illegal additive sibutramine,N-single demethylated sibutramine in healthy food
原文传递
导出
摘要 目的建立保健食品中非法添加物西布曲明、N-单去甲基西布曲明质控样品的研制流程。方法采用超高效液相色谱-串联质谱法(UPLC-MS),Agilent ZORBAX SB-C18色谱柱(2.1 mm×100 mm,3.5μm),流动相缓冲液(含10 mmol/L乙酸铵和0.1%乙酸)和乙腈,电喷雾电离,多反应检测模式(MRM),对质控样品中西布曲明、N-单去甲基西布曲明进行了含量测定,并进行了方法学验证,均匀性和稳定性评价,以及不确定度的计算。结果西部曲明、N-单去甲基西布曲明的含量分别为(4.137±0.435)mg/kg、(5.033±0.545)mg/kg。结论本实验对保健食品中非法添加物西布曲明,N-单去甲基西布曲明进行了分析测量和定值,该研制流程符合相关要求,可用于质量控制样品定值的参考。 Objective To establish a development process of quality control samples for illegal addictive sibutramine and N-single demethylated sibutramine in healthy food. Methods Ultra- performance liquid chromatography- tandem mass spectrum( UPLC- MSMS) technology,Agilent ZORBAX SB- C18column( 2. 1 mm × 100 mm,3. 5 μm),mobile phase of 10 mmol / L ammonium acetate and 0. 1% acetonitrile,electrospray ionization,multi reaction detection mode( MRM) were used for the detection of sibutramine and N- single demethylated sibutramine in quality control samples,and then the methodology,homogeneity and stability test were completed. At last,the uncertainty about the results was calculated. Results The contents of sibutramine and N- single demethylated sibutramine were respectively( 4. 137 ± 0. 435) mg / kg and( 5. 033 ± 0. 545) mg / kg. Conclusion This article detected and certificated the sibutramine and N- single demethylated sibutramine in healthy food. The process matched related standards and could be used as the reference in certification of quality control samples.
出处 《中国卫生检验杂志》 CAS 2016年第21期3075-3079,3082,共6页 Chinese Journal of Health Laboratory Technology
关键词 质控样品 西布曲明 N-单去甲基西布曲明 不确定度 Quality control sample Sibutramine N-single demethylated sibutramine Uncertainty
  • 相关文献

参考文献3

二级参考文献24

  • 1刘敏,李玉兰,秦斌,邓颖.国家对照品舒巴坦钠的协作标定[J].天津药学,2005,17(2):23-25. 被引量:1
  • 2中华人民共和国卫生部.化妆品卫生规范(2007年版)[S].2007:167-184.
  • 3国家技术监督局.JJGl006-94一级标准物质计量技术规范[S].中国计量出版社,1994.
  • 4全浩标准物质及其应用技术[M].北京:中国标准出版社,1991:106-108.
  • 5国家计量局.中华人民共和国计量法[M].北京:法律出版社,1985:2-5.
  • 6药品注册管理办法[S].国家食品药品监督管理局令第28号,2007.
  • 7VINCENT M, ELISABETH N, PHIIPPE S. Brief communi- cation: case reports of ribavirin treatment for chronic hepatitis E [ J ]. Ann Int Med, 2010,153 ( 2 ) :85-89.
  • 8REICHARD O, ANDERSON J, SCHVARCZ R, et al. Riba- virin treatment for chronic hepatitis C [ J ]. Lancet, 1991,337 (8749) :1058-1061.
  • 9GARNIER J L,CHEVALLIER P,DUBERNARD J M,et al. Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients [ J ]. Transplant Proc, 1997,29 ( 1 ) :783.
  • 10FONTINE H, VALLET A, SELVES J, et al. Histopathologie efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C [ J ]. Transplantation, 2004,78(6) :853-857.

共引文献20

同被引文献86

引证文献9

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部